Steven A. Shallcross
Chief Financial Officer, Vanda Pharmaceuticals Inc.
Companies
- Theriva Biologics, Inc.Board member Dec 7, 2018 to now1
- Theriva Biologics, Inc.Chief executive officer Dec 21, 2017 to now2
- Theriva Biologics, Inc.Chief financial officer Jun 1, 2015 to now3
- Elys BMG Group, Inc.Board member Jun 18, 2019 to Feb 16, 20234
- Twin Vee PowerCats, Co.Board member Jul 20, 2021 to Jul 26, 20215
- Nuo Therapeutics, Inc.Chief financial officer Aug 21, 2014 to Aug 27, 20146
- Nuo Therapeutics, Inc.Officer Apr 4, 2013 to Jun 20, 20147
- Vanda Pharmaceuticals Inc.Chief financial officer Apr 12, 2006 to Jan 8, 20088
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Theriva Biologics, Inc. TOVX250,000 shares9$52.5K at $0.21Jun 7, 2023
- Elys BMG Group, Inc.27,717 shares10Feb 14, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 7, 2023Bought 14,000 shares at $0.69 of Theriva Biologics, Inc.9
- Jun 6, 2023Bought 26,000 shares at $0.63 of Theriva Biologics, Inc.11
- Feb 14, 2023Granted 22,472 shares at $0.89 of Elys BMG Group, Inc.10
- Feb 10, 2023Bought 25,000 shares at $1.04 of Theriva Biologics, Inc.12
- Feb 2, 2023Bought 25,000 shares at $0.94 of Theriva Biologics, Inc.13
- Jan 25, 2023Bought 25,000 shares at $0.87 of Theriva Biologics, Inc.14
- Jan 20, 2023Bought 25,000 shares at $0.75 of Theriva Biologics, Inc.15
- Dec 29, 2022Bought 100,000 shares at $0.44 of Theriva Biologics, Inc.16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARElys BMG Group, Inc., Board member
- 5
- 6
- 7SEC EDGARNuo Therapeutics, Inc., Officer
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 7, 2023
- 12SEC EDGARForm 4 filed Feb 13, 2023
- 13SEC EDGARForm 4 filed Feb 3, 2023
- 14SEC EDGARForm 4 filed Jan 26, 2023
- 15SEC EDGARForm 4 filed Jan 23, 2023
- 16SEC EDGARForm 4 filed Jan 3, 2023